• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Logo
  • COVID-19 Resource Center
  • Categories
    • Feature
    • Cardiology trends
    • Cardiology research news
    • Conference coverage
    • Consensus reports & Position papers
    • Resources for Cardiology Professionals
    • COVID-19 Resource Center
  • Videos
  • Cardiology Best Practices

Cardiology Update

The latest trends and advancements made in cardiology research.

Recommendations from a scientific expert panel on the transition to high-sensitivity troponin testing

April 30, 2019

Reading Time: 2 minutes

Cardiac troponin (cTn) assays have been widely used worldwide to assess myocardial injury. Recently, new high sensitivity cardiac troponin (hs-cTn) methods have been introduced. A JACC scientific expert panel provided instructions and recommendations for institutions experiencing the transition from traditional to hs-cTn assays.

The innovative hs-cTn assays allow more precise troponin detection at lower concentrations, as compared to traditional methods, due to a better signal-to-noise ratio provided by the presence of specific antibody reagents. Importantly, the unit of measure for reporting hs-cTn concentrations is ng/l instead of the previously used ng/ml for cTn. The ng/l unit of measure results in integer numbers for troponin concentration instead of fractional ones (e.g. 25 ng/l vs 0.025 ng/ml), potentially increasing clarity and safer clinical interpretation. Concerning cutoff values for hs-cTn, Januzzi et. al advise to adopt gender-specific ones for decision-making.

A crucial aspect concerning troponin testing is establishing standardized protocols to diagnose acute myocardial infarction (AMI) in emergency department (ED) patients with acute coronary syndrome (ACS) symptoms. An increase in troponin above the 99th percentile of a normal population is generally considered abnormal. However, increased troponin alone, which identifies myocardial injury, is not enough to diagnose AMI. Serial sampling and changes in hs-cTn, together with coronary ischemic symptoms, are essential for AMI diagnosis. The expert panel advises to establish specific cutoffs for each individual to identify rise and fall in hs-cTn, based on respective baseline concentration values. Suggested changes in thresholds range from 50 to 80% of baseline troponin concentration. Currently, so-called accelerated diagnostic protocols (ADP) are used in ED to rule out the presence of AMI. Therefore, these rapid algorithms need to have high sensitivity and high negative predictive value, minimizing the risk of post-discharge complications. For early presenters (less than 3 hours from symptom onset), the advised procedure is to perform serial testing of hs-cTn (baseline measurement plus a second one after 1, 2 or 3 hours), to be assessed together with a validated risk score, such as HEART (History, ECG, Age, Risk Factors and Troponin) or EDACS (Emergency Department Assessment of Chest Pain Score). For patients presenting after 3 hours from symptom onset, it is suggested to examine hs-cTn at baseline and after 1 hour. In patients > 3 hour symptom onset, a single hs-cTn test is advised for ruling out MI, whereby very low troponin concentration (less than the limit of detection) and no ischemia on the ECG would be sufficient.

For non-ED patients in the hospital setting with acute chest pain symptoms, a baseline plus 3 hour hs-cTn measurement approach is advised. Caution in the results’ interpretation should be taken by assessing the whole clinical scenario and by considering that the presence of comorbidities, such as diabetes mellitus, chronic kidney disease, heart failure and left ventricular hypertrophy, concurs to myocardial injury and may cause chronic elevation of troponin.

For outpatients with stable chest pain symptoms, there is a lack of sufficient supporting information concerning troponin testing. The expert panel does not recommend a single-test approach, which should be confined to an ED setting.

In general, the expert panel advises to have a consistent transition from one method to the other across all departments and services of an institution, following gradual and dedicated training of all personnel involved in this practice. Specific strategies should be defined and standardized, tailoring them to the specific needs of the department and institution.

Original article: J Am Coll Cardiol 2019;73:1059-1077 

Author: Lorena Casadonte, Cardiology Update


 


Check Out Related Articles

  • COVID-19 Clinical Characteristics & Risk Factors for Death and TransmissionCOVID-19 Clinical Characteristics & Risk Factors for Death and Transmission
  • CT angiography vs stress testing for diabetic patients with suspected CADCT angiography vs stress testing for diabetic patients with suspected CAD
  • COVID-19 and the HeartCOVID-19 and the Heart

Primary Sidebar

Cardiology News Highlights

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Most featured

Statin therapy: clinical benefits and potential risks

Statin therapies prevent both primary and secondary cardiovascular disease.However, long term safety … Continue Reading about Statin therapy: clinical benefits and potential risks

Cardiology Conferences 2021

Top Cardiology Conferences 2021

With the COVID-19 worldwide pandemic, conferences and congresses planned for 2020 converted to … Continue Reading about Top Cardiology Conferences 2021

N of 1 Trial - Statin side effects

SAMSON Trial: Role of nocebo effect in statin-associated muscle symptoms

The phenomenon of non-adherence to statin therapy is well known. Reasons for discontinuation include … Continue Reading about SAMSON Trial: Role of nocebo effect in statin-associated muscle symptoms

Browse by topic

Cardiac surgery Electrophysiology General cardiology Heart failure Imaging Interventional cardiology

Footer

Cardiology Update

Providing up-to-date developments in the field of cardiology in a clear and concise manner. All articles are written by professional medical journalists and subsequently reviewed by our editorial board. Cardiology Update provides breaking news, that matter to healthcare professionals in the field of cardiology. Subscribe for free to keep up with cardiology news updated regularly.

Learn More About Us

Contact Us

Recent

  • Top Cardiology Conferences 2021
  • SAMSON Trial: Role of nocebo effect in statin-associated muscle symptoms
  • Top 10 Highlights of AHA 2020 Congress
  • Thromboembolism in COVID-19 patients despite thromboprophylaxis
  • Top 10 highlights of TCT 2020 Congress

Search

Browse by topic

Cardiac surgery Electrophysiology General cardiology Heart failure Imaging Interventional cardiology

Terms & Conditions | Privacy | Disclaimer
© Clinicalinx B.V. All rights reserved. Postbus 2278, 1000 CG Amsterdam

We use cookies to provide the services and features offered on our website, and to improve our user experience. Learn more Ok
Privacy & Cookies Policy
Necessary Always Enabled